These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3436616)

  • 41. Is the mammosomatotrope a transitional cell for the functional interconversion of growth hormone- and prolactin-secreting cells? Suggestive evidence from virgin, gestating, and lactating rats.
    Porter TE; Hill JB; Wiles CD; Frawley LS
    Endocrinology; 1990 Dec; 127(6):2789-94. PubMed ID: 2123441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of hydrocortisone on basal and apomorphine-induced growth hormone secretion in normal subjects.
    Lal S; Nair NP; Isaac I; Guyda H; Quirion R
    Clin Invest Med; 1988 Jun; 11(3):218-23. PubMed ID: 3402107
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects.
    Loche S; Cambiaso P; Carta D; Setzu S; Imbimbo BP; Borrelli P; Pintor C; Cappa M
    J Clin Endocrinol Metab; 1995 Feb; 80(2):674-8. PubMed ID: 7852535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prolactin response to TRH in insulin-dependent diabetes mellitus].
    Gragnoli G; Tanganelli I; Signorini AM
    Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1989-95. PubMed ID: 6779839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Naloxone reduces the fenfluramine-induced prolactin release in man.
    Foresta C; Scanelli G; Indino M; Federspil G; Scandellari C
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):539-43. PubMed ID: 3987071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers.
    Miell JP; Corder R; Pralong FP; Gaillard RC
    J Clin Endocrinol Metab; 1991 Mar; 72(3):675-81. PubMed ID: 1671785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of pyridostigmine on growth hormone (GH) response to GH-releasing hormone pre- and postprandially in normal and obese subjects.
    De Marinis L; Mancini A; Zuppi P; Calabrò F; Fiumara C; Lagonigro G; Fabrizi ML; Sammartano L
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1253-7. PubMed ID: 1592867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of obesity and morbid obesity on the growth hormone (GH) secretion elicited by the combined GHRH + GHRP-6 test.
    Kelestimur F; Popovic V; Leal A; Van Dam PS; Torres E; Perez Mendez LF; Greenman Y; Koppeschaar HP; Dieguez C; Casanueva FF
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):667-71. PubMed ID: 16712669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.
    Orio F; Palomba S; Colao A; Russo T; Dentico C; Tauchmanovà L; Savastano S; Nappi C; Sultan C; Zullo F; Lombardi G
    J Endocrinol Invest; 2003 Feb; 26(2):117-22. PubMed ID: 12739737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arginine normalizes the growth hormone (GH) response to GH-releasing hormone in adult patients receiving chronic daily immunosuppressive glucocorticoid therapy.
    Giustina A; Bossoni S; Bodini C; Girelli A; Balestrieri GP; Pizzocolo G; Wehrenberg WB
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1301-5. PubMed ID: 1592874
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Basic fibroblastic growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation.
    Atkin SL; Landolt AM; Jeffreys RV; Diver M; Radcliffe J; White MC
    J Clin Endocrinol Metab; 1993 Sep; 77(3):831-7. PubMed ID: 8370706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
    Rasmussen MH; Hvidberg A; Juul A; Main KM; Gotfredsen A; Skakkebaek NE; Hilsted J; Skakkebae NE
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1407-15. PubMed ID: 7536210
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impaired growth hormone response to insulin-induced hypoglycaemia in obese patients: restoration blocked by ritanserin after fenfluramine administration.
    Bernini GP; Argenio GF; Vivaldi MS; Del Corso C; Birindelli R; Luisi M; Franchi F
    Clin Endocrinol (Oxf); 1990 Apr; 32(4):453-9. PubMed ID: 2112069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of anorexiant drugs on growth hormone secretion in obese children.
    Baritussio A; Enzi G; Rigon G; Molinari M; Inelmen EM; Crepaldi G
    Pharmacol Res Commun; 1978 Jun; 10(6):529-40. PubMed ID: 693565
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effect of 5-hydroxytryptophan on the secretion of PRL, GH, TSH and cortisol in obesity].
    Martinelli I; Mainini E; Mazzi C
    Minerva Endocrinol; 1992; 17(3):121-6. PubMed ID: 1298871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of gonadal steroids in the serotoninergic control of prolactin secretion in men.
    Foresta C; Indino M; Scandellari C
    Clin Endocrinol (Oxf); 1987 May; 26(5):601-7. PubMed ID: 3665121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of prosomatostatin on growth hormone and prolactin response to arginine in man. Comparison with somatostatin.
    Rodriguez-Arnao MD; Gomez-Pan A; Rainbow SJ; Woodhead S; Comaru-Schally AM; Schally AV; Meyers CA; Coy DH; Hall R
    Lancet; 1981 Feb; 1(8216):353-6. PubMed ID: 6109991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disordered growth hormone and prolactin secretion in primary disorders of sleep.
    Clark RW; Schmidt HS; Malarkey WB
    Neurology; 1979 Jun; 29(6):855-61. PubMed ID: 572007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simultaneous study of cortisol, growth hormone and prolactin nyctohemeral variations in normal and obese subjects. Influence of prolonged fasting in obesity.
    Copinschi G; De Laet MH; Brion JP; Leclercq R; L'Hermite M; Robyn C; Virasoro E; Van Cauter E
    Clin Endocrinol (Oxf); 1978 Jul; 9(1):15-26. PubMed ID: 679499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.